Squadron Capital Management LLC

Squadron Capital Management LLC reported 45 holdings worth US$398M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Squadron Capital Management LLC reported 45 holdings worth US$398M as of Sep 30, 2026. Largest: Kodiak Sciences Inc, C4 Therapeutics, Inc. and Cogent Biosciences, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
45
Value as reported
US$398M

The filing in full

CompanySharesValue as reported% of portfolio
Kodiak Sciences Inc420KUS$39.8M10.0%
C4 Therapeutics, Inc.9.32MUS$31M7.8%
Cogent Biosciences, Inc.915KUS$29.3M7.4%
Silence Therapeutics PLC2.08MUS$22.8M5.7%
Zentalis Pharmaceuticals, Inc.6.83MUS$18.9M4.7%
Edgewise Therapeutics, Inc.425KUS$17.3M4.3%
Relay Therapeutics, Inc.785KUS$14.2M3.6%
ORIC Pharmaceuticals, Inc.1MUS$13.5M3.4%
Relmada Therapeutics, Inc.3.5MUS$13.2M3.3%
Definium Therapeutics, Inc.340KUS$12.9M3.2%
Adlai Nortye Group Ltd.765KUS$12.2M3.1%
Vera Therapeutics, Inc.305KUS$9.85M2.5%
Inventiva SA2.4MUS$8.86M2.2%
Avalo Therapeutics, Inc.450KUS$6.9M1.7%
Aclaris Therapeutics, Inc.1.2MUS$6.31M1.6%
Assembly Biosciences, Inc.225KUS$5.29M1.3%
Adagene, Inc.1.62MUS$5.17M1.3%
Crescent Biopharma, Inc.350KUS$5.11M1.3%
Zura Bio Limited1.2MUS$4.99M1.3%
TCGX Acquisition Corp.370KUS$4.63M1.2%
Contineum Therapeutics, Inc.324KUS$4.34M1.1%
Inhibikase Therapeutics, Inc.2MUS$4.11M1.0%
Palisade Bio, Inc.3MUS$4.05M1.0%
Tango Therapeutics, Inc.150KUS$3.74M0.94%
Janux Therapeutics, Inc.215KUS$3.72M0.93%
Savara, Inc.675KUS$3.48M0.87%
JATT III Acquisition Corp250KUS$2.75M0.69%
ALX Oncology Holdings Inc.1.4MUS$1.95M0.49%
Lipocine Inc.810KUS$1.78M0.45%
PepGen Inc.600KUS$1.45M0.36%
JATT II Acquisition Corp65,000US$731K0.18%
Enliven Therapeutics, Inc.0US$00.00%
Forte Biosciences, Inc.0US$00.00%
InMed Pharmaceuticals Inc.0US$00.00%
Maze Therapeutics, Inc.0US$00.00%
Neumora Therapeutics, Inc.0US$00.00%
NextCure, Inc.0US$00.00%
Pasithea Therapeutics Corp.0US$00.00%
ProMIS Neurosciences Inc.0US$00.00%
Rezolute, Inc.0US$00.00%
BioAge Labs, Inc.0US$00.00%
CalciMedica, Inc.0US$00.00%
Cue Biopharma, Inc.0US$00.00%

Source

Download original · View original at SEC

Related